CN105873922B - 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 - Google Patents
9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 Download PDFInfo
- Publication number
- CN105873922B CN105873922B CN201480071487.0A CN201480071487A CN105873922B CN 105873922 B CN105873922 B CN 105873922B CN 201480071487 A CN201480071487 A CN 201480071487A CN 105873922 B CN105873922 B CN 105873922B
- Authority
- CN
- China
- Prior art keywords
- alkyl
- compound
- diyl
- tetrafluoro
- imidazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C(CCC1)*1S)C1=CC1 Chemical compound CC(C(CCC1)*1S)C1=CC1 0.000 description 15
- QSXSEJCNAQXQHO-SECBINFHSA-N CC(C)CC(N1[C@H](C)CCC1)=O Chemical compound CC(C)CC(N1[C@H](C)CCC1)=O QSXSEJCNAQXQHO-SECBINFHSA-N 0.000 description 1
- IXASGYGVTFHMJV-UHFFFAOYSA-N CC(c(cc1C2(F)F)ccc1-c1ccc(C)cc1C2(F)F)=O Chemical compound CC(c(cc1C2(F)F)ccc1-c1ccc(C)cc1C2(F)F)=O IXASGYGVTFHMJV-UHFFFAOYSA-N 0.000 description 1
- ZEZSJUCASSTLAQ-IDRRIYIWSA-N CC[C@@H](C(N([C@H]1C[C@@H]2CC1)[C@@H]2c1ncc(-c(cc2)cc(CF)c2-c(cc2)c(C(CF)(F)F)cc2-c2cnc([C@H]([C@@H]3C[C@H](C)CC3)NC([C@H]([C@@H](C)O)NC(OC)=O)=O)[nH]2)[nH]1)=O)NC(OC)=O Chemical compound CC[C@@H](C(N([C@H]1C[C@@H]2CC1)[C@@H]2c1ncc(-c(cc2)cc(CF)c2-c(cc2)c(C(CF)(F)F)cc2-c2cnc([C@H]([C@@H]3C[C@H](C)CC3)NC([C@H]([C@@H](C)O)NC(OC)=O)=O)[nH]2)[nH]1)=O)NC(OC)=O ZEZSJUCASSTLAQ-IDRRIYIWSA-N 0.000 description 1
- BPXCLLWXDHBFRH-UHFFFAOYSA-N COCCC(N)=O Chemical compound COCCC(N)=O BPXCLLWXDHBFRH-UHFFFAOYSA-N 0.000 description 1
- PAISMPKJXOZRKI-UHNVWZDZSA-N C[C@H]([C@@H](C(O)=O)NC(OC)=O)OC Chemical compound C[C@H]([C@@H](C(O)=O)NC(OC)=O)OC PAISMPKJXOZRKI-UHNVWZDZSA-N 0.000 description 1
- NXJIXUDWOLZVPL-UHFFFAOYSA-N O=C(CBr)c(cc1C(C2(F)F)(F)F)ccc1-c(cc1)c2cc1Br Chemical compound O=C(CBr)c(cc1C(C2(F)F)(F)F)ccc1-c(cc1)c2cc1Br NXJIXUDWOLZVPL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013107543184 | 2013-12-31 | ||
| CN201310754318 | 2013-12-31 | ||
| PCT/CN2014/095043 WO2015101215A1 (zh) | 2013-12-31 | 2014-12-26 | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105873922A CN105873922A (zh) | 2016-08-17 |
| CN105873922B true CN105873922B (zh) | 2018-08-14 |
Family
ID=53493209
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480071487.0A Active CN105873922B (zh) | 2013-12-31 | 2014-12-26 | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 |
| CN201410835606.7A Active CN104744444B (zh) | 2013-12-31 | 2014-12-29 | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410835606.7A Active CN104744444B (zh) | 2013-12-31 | 2014-12-29 | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9512108B2 (enExample) |
| EP (1) | EP3091010A4 (enExample) |
| JP (1) | JP2017536329A (enExample) |
| KR (1) | KR101857689B1 (enExample) |
| CN (2) | CN105873922B (enExample) |
| AU (1) | AU2014375584B2 (enExample) |
| CA (1) | CA2935089C (enExample) |
| TW (1) | TWI532735B (enExample) |
| WO (1) | WO2015101215A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107266424A (zh) * | 2016-04-07 | 2017-10-20 | 南京圣和药业股份有限公司 | 二氢菲类化合物及其制备方法 |
| CN108623569A (zh) * | 2017-03-21 | 2018-10-09 | 南京圣和药业股份有限公司 | 9,10-二氢菲类化合物的制备方法 |
| CN108623570A (zh) * | 2017-03-21 | 2018-10-09 | 南京圣和药业股份有限公司 | 9,10-二氢菲类化合物、其制备方法及用途 |
| CN108619102A (zh) * | 2017-03-21 | 2018-10-09 | 南京圣和药业股份有限公司 | 一种包含丙型肝炎病毒抑制剂的药物组合物及其制备方法 |
| CN108623568B (zh) * | 2017-03-21 | 2022-04-19 | 南京汇诚制药有限公司 | 9,10二氢菲类丙型肝炎病毒抑制剂的盐型及其制备 |
| CN109419806B (zh) * | 2017-08-23 | 2023-06-20 | 南京圣和药业股份有限公司 | 抗病毒组合物及其应用 |
| CN114890916A (zh) * | 2022-04-25 | 2022-08-12 | 常州吉恩药业有限公司 | 一种n-甲氧羰基-l-叔亮氨酸的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012068234A2 (en) * | 2010-11-17 | 2012-05-24 | Gilead Sciences, Inc. | Antiviral compounds |
| CN102596936A (zh) * | 2009-05-13 | 2012-07-18 | 吉里德科学公司 | 抗病毒化合物 |
| WO2013028953A1 (en) * | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Combination treatments for hepatitis c |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19524230A1 (de) * | 1995-07-04 | 1997-01-09 | Hoechst Ag | Fluorierte Phenanthren-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| US6455744B1 (en) * | 2001-01-23 | 2002-09-24 | Air Products And Chemicals, Inc. | Synthesis of vicinal difluoro aromatics and intermediates thereof |
-
2014
- 2014-12-26 CA CA2935089A patent/CA2935089C/en not_active Expired - Fee Related
- 2014-12-26 KR KR1020167011524A patent/KR101857689B1/ko not_active Expired - Fee Related
- 2014-12-26 WO PCT/CN2014/095043 patent/WO2015101215A1/zh not_active Ceased
- 2014-12-26 EP EP14876481.4A patent/EP3091010A4/en not_active Withdrawn
- 2014-12-26 AU AU2014375584A patent/AU2014375584B2/en not_active Ceased
- 2014-12-26 CN CN201480071487.0A patent/CN105873922B/zh active Active
- 2014-12-26 JP JP2016531709A patent/JP2017536329A/ja active Pending
- 2014-12-26 US US15/030,990 patent/US9512108B2/en not_active Expired - Fee Related
- 2014-12-29 CN CN201410835606.7A patent/CN104744444B/zh active Active
- 2014-12-31 TW TW103146591A patent/TWI532735B/zh not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102596936A (zh) * | 2009-05-13 | 2012-07-18 | 吉里德科学公司 | 抗病毒化合物 |
| WO2012068234A2 (en) * | 2010-11-17 | 2012-05-24 | Gilead Sciences, Inc. | Antiviral compounds |
| WO2013028953A1 (en) * | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Combination treatments for hepatitis c |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105873922A (zh) | 2016-08-17 |
| KR20160058187A (ko) | 2016-05-24 |
| JP2017536329A (ja) | 2017-12-07 |
| CA2935089A1 (en) | 2015-07-09 |
| TW201524973A (zh) | 2015-07-01 |
| CN104744444B (zh) | 2019-02-26 |
| KR101857689B1 (ko) | 2018-05-14 |
| CA2935089C (en) | 2018-11-27 |
| AU2014375584B2 (en) | 2017-11-09 |
| US9512108B2 (en) | 2016-12-06 |
| TWI532735B (zh) | 2016-05-11 |
| EP3091010A1 (en) | 2016-11-09 |
| CN104744444A (zh) | 2015-07-01 |
| EP3091010A4 (en) | 2017-10-04 |
| US20160297804A1 (en) | 2016-10-13 |
| WO2015101215A1 (zh) | 2015-07-09 |
| AU2014375584A1 (en) | 2016-07-07 |
| HK1222845A1 (zh) | 2017-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105873922B (zh) | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 | |
| TWI438200B (zh) | C型肝炎病毒抑制劑 | |
| ES2383388T3 (es) | Inhibidores del virus de la hepatitis C | |
| CN102459250B (zh) | 丙型肝炎病毒抑制剂 | |
| CN102378762B (zh) | 丙型肝炎病毒抑制剂 | |
| CN102863428B (zh) | 作为丙型肝炎病毒抑制剂的螺环化合物 | |
| CN102015692A (zh) | 丙型肝炎病毒抑制剂 | |
| CN104230946B (zh) | 抑制丙肝病毒的化合物、药物组合物及其应用 | |
| CN104725365B (zh) | 丙型肝炎病毒抑制剂及其应用 | |
| AU2010274001A1 (en) | Benzimidazole analogues for the treatment or prevention of Flavivirus infections | |
| SG171890A1 (en) | Inhibitors of hcv ns5a | |
| KR20120130173A (ko) | 플라비바이러스 감염을 치료 또는 예방하기 위한 유사체들 | |
| JP2014534206A (ja) | C型肝炎ウイルス阻害剤 | |
| CN103420991A (zh) | 作为丙型肝炎抑制剂的吡咯烷衍生物及其在药物中的应用 | |
| TW201439060A (zh) | 作爲丙型肝炎抑制劑的橋環化合物及其藥物組合物和用途 | |
| CN106008552B (zh) | 苯并[e]吡唑并[1,5-c][1,3]噁嗪类化合物及其应用 | |
| AU2014396578A1 (en) | Compounds for inhibiting hepatitis C virus, pharmaceutical compositions and uses thereof | |
| CN107074876B (zh) | 一类抑制丙肝病毒的大环状杂环化合物及其制备和用途 | |
| HK1222845B (zh) | 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用 | |
| CN108348504B (zh) | 具有抑制hcv活性的化合物及其制备方法和应用 | |
| CN105985355B (zh) | 稠合三环类肝炎病毒抑制剂及其应用 | |
| WO2017088730A1 (zh) | 用于抗丙型肝炎病毒感染的含硅化合物 | |
| JP2020512331A (ja) | 抗c型肝炎ウイルス感染のためのケイ素含有化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1222845 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |